Rashna Mirza | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Ms. Rashna Mirza | Pharmaceutical Science | Best Researcher Award

PhD scholar of Quaid-i-Azam University, Pakistan.

Rashna Mirza is a distinguished researcher currently pursuing a PhD at Quaid-i-Azam University, Islamabad, focusing on advanced drug delivery systems, including brain-targeted transfersomes and optimized nano-transfersomes. A Gold Medalist in Pharm D from People’s University of Medical and Health Sciences for Women, she has demonstrated exceptional academic and research prowess. Her professional experience includes roles in quality assurance, pharmaceutical research, and laboratory supervision, showcasing her expertise in drug formulation and optimization. Rashna’s commitment to the field is reflected in her impactful publications and active participation in conferences. Her strengths lie in cutting-edge research, scientific communication, and organizational skills, though expanding her research impact and gaining leadership experience could further enhance her profile. Rashna’s background and achievements make her a strong candidate for the Research for Best Researcher Award.

Profile

Education

Rashna Mirza’s educational background reflects her strong commitment to the field of pharmaceutics. She is currently pursuing a PhD at Quaid-i-Azam University, Islamabad, with research focused on advanced drug delivery systems, including brain targeting of Cefepime-loaded transfersomes and optimization of nano-transfersomes for transdermal delivery. Prior to her PhD, Rashna completed her M.Phil at the same institution, where she continued to build on her expertise in pharmaceutics. She earned her Pharm D from People’s University of Medical and Health Sciences for Women, where she graduated as a Gold Medalist, underscoring her exceptional academic performance. Rashna’s foundational education includes an FSC Pre-Medical from Government Girls Degree College, Islamabad, and matriculation from Foundation Public School, Karachi. This robust educational background has equipped her with a deep understanding of pharmaceutical sciences and a solid foundation for her research career.

Professional Experience

Rashna Mirza has a diverse professional background that underscores her expertise in pharmaceutics and drug development. Currently pursuing her PhD at Quaid-i-Azam University, she is engaged in pioneering research on brain-targeted drug delivery systems and transdermal gels. Her experience includes working as a Lab Demonstrator at Quaid-i-Azam University, where she managed laboratory work, supervised experiments, and facilitated instructional activities. She also served as a Quality Assurance Inspector at Herbiotics, where she conducted inspections, quality audits, and process monitoring. Additionally, Rashna worked as a Retail Pharmacist at Punjab Pharmacy, handling inventory management, patient counseling, and medication therapy management. Her academic journey is marked by her gold medal achievement in Pharm D from People’s University of Medical and Health Sciences for Women. Her professional roles reflect her strong organizational, supervisory, and research skills, contributing significantly to her field.

Research Interest

Rashna Mirza’s research interests center on the development and optimization of novel drug delivery systems to enhance therapeutic outcomes. Her current PhD research focuses on innovative approaches such as brain-targeting of Cefepime-loaded transfersomes and the formulation of nano-transfersomes-based chitosan gels for transdermal delivery. This work aims to improve drug efficacy and patient compliance through advanced delivery mechanisms. Rashna is also interested in the formulation and optimization of thermosensitive in situ gels, exploring their potential for controlled and targeted drug release. Her research integrates both in vitro and in vivo studies to address challenges in pharmaceutical science, emphasizing the importance of precise drug delivery for effective treatment. Rashna’s work is characterized by a commitment to advancing pharmaceutics through rigorous experimentation and collaboration, contributing valuable insights to the field and aiming to bridge gaps in current drug delivery technologies.

Research Skills

Rashna Mirza exhibits a strong suite of research skills that underscore her capabilities in advancing the field of pharmaceutics. Her expertise in drug formulation and optimization is evident through her current PhD research, which involves innovative drug delivery systems such as brain-targeting transfersomes and nano-transfersomes. Rashna’s proficiency in statistical design and optimization further enhances her ability to develop and refine novel drug delivery methods. Her hands-on laboratory skills are complemented by her experience in quality assurance and process monitoring, ensuring meticulous evaluation and control of research processes. Additionally, Rashna’s solid background in scientific communication and report writing enables her to effectively present and disseminate research findings. Her involvement in interdisciplinary collaboration and active participation in conferences reflects her commitment to integrating diverse perspectives and advancing scientific knowledge. Overall, Rashna’s research skills demonstrate a well-rounded and impactful approach to pharmaceutics and drug development.

Award and Recognition

Rashna Mirza, a distinguished researcher and Gold Medalist in Pharm D, has garnered significant recognition for her contributions to the field of pharmaceutics. Her innovative research on drug delivery systems, including brain-targeting transfersomes and nano-transfersome optimization, has been widely acknowledged within the scientific community. Rashna’s work is prominently featured in impactful publications, reflecting her dedication to advancing drug formulation and optimization. Her role as a Lab Demonstrator and Quality Assurance Inspector highlights her exceptional skills in scientific communication, process improvement, and interdisciplinary collaboration. Additionally, Rashna’s participation in notable conferences and her involvement in quality audits further underscore her commitment to excellence in pharmaceutical research. These achievements collectively affirm her as a leading figure in her field, earning her well-deserved recognition and positioning her as a promising candidate for prestigious awards in pharmaceutics and drug development.

Conclusion

Rashna Mirza’s strong background in pharmaceutics, demonstrated research capabilities, and commitment to advancing drug delivery systems position her as a suitable candidate for the Research for Best Researcher Award. Her strengths in innovative research, academic excellence, and effective communication support her candidacy, while opportunities for broader impact and leadership development could further enhance her profile.

Publication Top Notes

  • Brain targeting of cefepime loaded transfersomes based thermosensitive in situ gel via intranasal delivery: In vitro and in vivo studies
    • Authors: R. Mirza, A.U. Khan, K.U. Shah, F. Alasmari, Z. Hafeez
    • Year: 2024
    • Citations: 1
  • Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime
    • Authors: R. Mirza, K.U. Shah, A.U. Khan, Z. Hafeez, S.U. Haq
    • Year: 2024

 

 

GHADEER SUAIFAN | Pharmaceutical Sciences | Best Researcher Award

Posted on by ScienceFather

Prof GHADEER SUAIFAN | Pharmaceutical Sciences | Best Researcher Award

Research Scholar, The University of Jordan, Jordan

Ghadeer A. Suaifan was born in December 1973 and is a Jordanian national. She is fluent in both Arabic and English. Ghadeer holds a PhD and an MPhil in Medicinal Chemistry and Instrumental Analysis from the University of Bath, UK, and a BSc (Honours) in Pharmacy from Petra University, Jordan. She currently serves as a Professor of Medicinal Chemistry and Pharmaceutical Instrumental Analysis at the Faculty of Pharmacy, The University of Jordan. Her research interests span medicinal chemistry, nanotechnology, and public health, with significant contributions in optimizing antidiabetic candidates, cancer treatments, and developing advanced analytical techniques. Ghadeer has published extensively and holds several patents.

Profile

Education🎓

From 2001 to 2004, Ghadeer A. Suaifan pursued a PhD in Medicinal Chemistry and Instrumental Analysis at the Department of Pharmacy and Pharmacology, University of Bath, UK. Prior to this, she completed an MPhil in Medicinal Chemistry and Instrumental Analysis at the same institution from 2000 to 2001. Ghadeer began her academic journey with a BSc (Honours) in Pharmacy from the College of Pharmacy, Petra University, Amman, Jordan, which she completed between 1991 and 1996. Her foundational education was acquired at Al-Room Al-Catholic School in Zarka, Jordan, where she earned her General Secondary Education Certificate from 1988 to 1991.

Experience 🏢

Prof. Ghadeer Suaifan is a distinguished Professor of Medicinal Chemistry and Pharmaceutical Instrumental Analysis at the Faculty of Pharmacy, The University of Jordan, where she has been serving since September 2016. In this role, she leads advanced research and teaching, significantly contributing to the academic and research excellence of the institution. Prior to this, she held the position of Associate Professor from September 2012 to September 2016, during which she focused on enhancing the curriculum and advancing research initiatives in medicinal chemistry and pharmaceutical sciences. From 2005 to 2012, Prof. Suaifan worked as an Assistant Professor at the same faculty, delivering undergraduate and postgraduate courses in pharmaceutical sciences and engaging in significant research activities. Additionally, she served as an Assistant Professor at the Faculty of Pharmacy, Philadelphia University, Amman, Jordan, from 2004 to 2005, where she contributed to the development of pharmaceutical education and research. Prof. Suaifan’s extensive experience and dedication have made her a vital asset to the field of pharmaceutical sciences in Jordan.

Research Interests 🔬

Ghadeer’s research encompasses Medicinal Chemistry and Instrumental Analysis, focusing on optimizing new antidiabetic candidates, elucidating molecular structures, and developing advanced prodrug systems for prostate cancer. Her work extends to Nanotechnology, including biological particle detection, miniaturized instrumentation, and medical diagnostics. She also investigates Public Research, evaluating antibiotic use behaviors and the prevalence of Complementary and Alternative Medicine in Jordan.

Special Awards 🏆

Professor Ghadeer Suaifan has been recognized for her outstanding contributions to research and development. She received the prestigious Ibtikar Award from Mewiin, Kuwait, in 2020. Her dedication to scientific research was further acknowledged with the Samia Mango Award from the Hamdi Mango Center for Scientific Research in Amman, Jordan, in 2018. In 2015, she was honored with the Excellent Oral Presenter Award at the International Conference on Pharmaceutical Sciences (ICPS) held in Dubai. Professor Suaifan’s academic achievements were consistently recognized during her time at the Faculty of Pharmacy, Petra University, where she received University Awards for Best Achievement from 1991 to 1996. In addition to her accolades, she has been a Registered Pharmacist with the Jordanian Pharmacists Association in Amman since January 1996, showcasing her longstanding commitment to the pharmaceutical profession and her continuous contributions to the field.

Publications Top Notes 📚

  1. Magnetic beads-based nanozyme for portable colorimetric biosensing of Helicobacter pylori
    • Authors: Suaifan, G.A.R.Y., Shehadeh, M.B., Darwish, R.M., Alaridah, N., Zourob, M.
    • Year: 2024
    • Journal: Biosensors and Bioelectronics: X, Volume 20, Article 100517
  2. Rapid Colorimetric Quantitative Portable Platform for Detection of Brucella melitensis Based on a Fluorescence Resonance Energy Transfer Assay and Nanomagnetic Particles
    • Authors: Alhogail, S., Chinnappan, R., Suaifan, G.A., Jürgen, P., Zourob, M.M.
    • Year: 2024
    • Journal: ACS Omega, Volume 9, Issue 19, Pages 20997–21005
  3. A cross-sectional study on adult lifestyle habits during the COVID-19 pandemic
    • Authors: Suaifan, G.A.R.Y., Abu-Odeh, A.M., Shehadeh, M.B., Jbara, W.A., Nassar, R.I.
    • Year: 2024
    • Journal: PLoS ONE, Volume 19, Issue 5, Article e0299668
  4. Synthesis, urease inhibitory and anticancer evaluation of glucosamine-sulfonylurea conjugates
    • Authors: Suaifan, G.A.R.Y., Shehadeh, M., Tahboub, D., Gaurav, A., Khan, M.
    • Year: 2024
    • Journal: Medicinal Chemistry Research, Volume 33, Issue 4, Pages 663–676
  5. Glucosamine substituted sulfonylureas: IRS-PI3K-PKC-AKT-GLUT4 insulin signalling pathway intriguing agent
    • Authors: Suaifan, G.A.R.Y., Alkhawaja, B., Shehadeh, M.B., Hor Kuan, C., Okechukwu, P.N.
    • Year: 2024
    • Journal: RSC Medicinal Chemistry, Volume 15, Issue 2, Pages 695–703
  6. Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants
    • Authors: Aloraij, Y.M., Suaifan, G.A.R.Y., Shibl, A., Al-Kattan, K., Zourob, M.M.
    • Year: 2023
    • Journal: ACS Omega, Volume 8, Issue 36, Pages 32877–32883
  7. Medicinal plants of Jordan: Scoping review
    • Authors: Abu-Odeh, A., Fino, L., Al-Absi, G., Shehadeh, M., Suaifan, G.
    • Year: 2023
    • Journal: Heliyon, Volume 9, Issue 6, Article e17081
  8. Antibiotic—Lysobacter enzymogenes proteases combination as a novel virulence attenuating therapy
    • Authors: Suaifan, G.A.R.Y., Abdel Rahman, D.M.A., Abu-Odeh, A.M., Shehadeh, M.B., Darwish, R.M.
    • Year: 2023
    • Journal: PLoS ONE, Volume 18, Issue 3, Article e0282705
  9. Knowledge, practice and attitude associated with SARS-CoV-2 Delta Variant among adults in Jordan
    • Authors: Suaifan, G.A.R.Y., Abu-Odeh, A.M., Shehadeh, M.B., Shahwan, M., Jbara, F.A.
    • Year: 2022
    • Journal: PLoS ONE, Volume 17, Issue 12, Article e0278243